News
NeuroSphere Announces New Ignite Grant Recipients
Published: 19 March 2021
NeuroSphere, 平特五不中鈥檚 neuroscience innovation accelerator, is pleased to announce the 12 award recipients from its second Ignite Grant Competition.
As the first of two phases in the HBHL Neuro-Commercialization Grants program,聽the objective of the Ignite Grants is聽to support small-scale validation and proof-of-principle efforts in the development of a neuroscience-related technology. The second phase of the program, the Accelerate Grants, is meant to support research aimed at improving a technology's commercial potential and to position it for commercial development.
Read more about the Ignite grants and see the recipients from both competitions.
Ignite Grant Competition II Recipients
| Principal Investigator | Project Title |
|---|---|
| Salah El Mestikawy | Development of LMB1-01-002, a first in class product candidate to target anorexia |
| Tuong-Vi Nguyen | Economic Impact Calculator for Perinatal Mental Health Disorders |
| Antonia Arnaert | Prototype Development of the 鈥淪mart Back鈥� Wearable Health Device to Prevent and Manage Recurrent Low Back Pain among Adults |
| Patr铆cia Pelufo Silveira | Building capacity for discovery and innovation in genomic datasets: the ePRS Cluster |
| Nancy Mayo | GoHand to Enhance Recovery of Arm and Hand Function Post-Stroke |
| Simon Wing | A Novel Assay for Identification of Inhibitors of a Deubiquitinating Enzyme for the Treatment of Parkinson's Disease |
| Derek Bowie | Stable expression cell line of a theraptuically relevant AMPA receptor |
| Timothy Kennedy | Polyglycerol dendrimer-based substrate for enhanced long-term cell culture |
| Philippe Gros | Structure of USP15/inhibitor complexes to guide the discovery of new anti-inflammatory drugs |
| Thomas Durcan | O2O - Organoid to Operator: The pathway to rapid and industry-standard dissemination of brain organoids to external users |
| Sylvain Williams | Development of machine learning neuronal decoders predicting preclinical drug efficacy for Alzheimer's disease |
| Amir Shmuel | Developing and evaluating methods for screening subjects and training subjects to stay still in mock scanners and MRI scanners |
